Bad medicine: type 2 diabetes
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1216 (Published 03 March 2010) Cite this as: BMJ 2010;340:c1216- Des Spence, general practitioner, Glasgow
- destwo{at}yahoo.co.uk
Type 2 diabetes is yet another “ticking time bomb.” With a tripling in the rate to 6% of UK men, and with general practitioners berated for the undiagnosed “missing million” cases, the number of people with diabetes is predicted to double in 20 years. The rationale for detection and treatment, supported by large observational studies, is to prevent cardiovascular and microvascular disease. This research also promotes aggressive control of glycated haemoglobin A1C, blood pressure, and cholesterol—a mantra of “the lower the better.” So people with diabetes are potentially prescribed three drugs to control …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.